Skip to content

John Wiley & Sons, Inc. WLYB Amortization of product development assets

Amortization of product development assets at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$100K-90.0%
MSCI logo
MSCIMSCI
$41.9M-4.6%
PDF Solutions logo
PDF SolutionsPDFS
$2.06M+94.8%
S&P Global logo
S&P GlobalSPGI
$276M+3.0%
RBC Bearings logo
RBC BearingsRBC
$21.4M+17.6%
Palo Alto Networks, Inc. logo
Palo Alto Networks, Inc.PANW
$37M

Other financials

Income statement

See full
Revenue$447.9M+1.2%
Gross profit$337.9M+1.9%
Operating income$110.1M+44.0%
Net income$135.3M+98.8%
EPS (diluted)$2.54+105%

Balance sheet

See full
Cash & equivalents$75.6M-11.9%
Total debt$768.9M-14.5%
Total equity$848.2M+12.8%
Total assets$2.6B-3.7%

Cash flow

See full
Operating cash flow$157.2M+4.6%
CapEx$13.2M-31.1%
Free cash flow$144.0M+9.8%

Valuation

See full
Market cap$2.33B-9.6%
Enterprise value$3.02B-11.0%
P/E10.5×-20.1×
P/S1.4×-0.1×

Profitability

See full
Gross margin74.3%0.0pp
Operating margin16.5%+3.3pp
Net margin13.2%+8.2pp
FCF margin12.5%+4.1pp

Returns & leverage

See full
Return on equity27.7%+16.4pp
Debt / equity0.9×-0.3×
Current ratio0.5×0.0×

Where this comes from

Reported directly by John Wiley & Sons, Inc. in its filing.

Tagged under the XBRL concept jwa:AmortizationOfProductDevelopmentAssets.

The official record: John Wiley & Sons, Inc.’s 10-K, filed June 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about John Wiley & Sons, Inc.'s amortization of product development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is John Wiley & Sons, Inc.'s amortization of product development assets?
John Wiley & Sons, Inc. (WLYB) reported amortization of product development assets of $4.35M in Q1 2026.
How has John Wiley & Sons, Inc.'s amortization of product development assets changed year-over-year?
John Wiley & Sons, Inc.'s amortization of product development assets increased by 10.4% year-over-year, from $3.94M to $4.35M.
What is the long-term trend for John Wiley & Sons, Inc.'s amortization of product development assets?
Over 5 years (2021 to 2026), John Wiley & Sons, Inc.'s amortization of product development assets has grown at a -14.1% compound annual growth rate (CAGR), from $34.37M to $16.06M.
What does amortization of product development assets mean?
This represents the systematic allocation of the cost of capitalized product development projects over their estimated useful lives. It reflects the ongoing consumption of intangible assets created through internal research and development efforts. High levels of this expense indicate significant historical investment in product innovation.